SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair - GZTR -- Ignore unavailable to you. Want to Upgrade?


To: BWAC who wrote (188)6/17/1999 5:46:00 PM
From: KLH  Read Replies (1) | Respond to of 405
 
The July/August issue of Men's Health magazine,
Carticle is covered on page 58 and 59, as the
answer in treating damaged knee cartilage. Too
bad the author didn't mention GZTR as the company
behind Carticle. Instead, they give a closing
paragraph to Advanced Tissue Sciences that is in
pre clinical FDA trials to grow "universal donor"
cartilage and its advantages over Carticle.


Karl